Bottom line
Is FCTGX a good fund? The bottom line
FCTGX is the Fidelity Advisor Small Cap Growth Fund: Class M share class of Fidelity Small Cap Growth Fund, a managed small-cap mutual fund from Fidelity.
Its expense ratio is 1.4% — about $140 a year on every $10,000 invested, more expensive than 82% of small-cap funds we track.
It returned +6.8% over one year, +4.4% a year over five years, +11.8% a year over ten (as of Sep 30, 2026, per its prospectus).
With $8.8 billion in net assets and 365 holdings, its largest position is Fidelity Revere Street Trust (4.3%) and the top 10 make up 14.2% of the portfolio.
What stands out
- Broadly diversified (365 holdings)
What to watch
- Expensive for its category (1.4%)
- 5-year return in the bottom quarter of its category
- 12b-1 marketing fee of 0.5% a year
Updated Nov 19, 2026
What FCTGX invests in
Fidelity Small Cap Growth Fund seeks capital appreciation.
Normally investing primarily in common stocks. Normally investing at least 80% of assets in securities of growth companies with small market capitalizations. The Adviser generally defines small market capitalization companies as those whose market capitalization is similar to the market capitalization of companies in the Russell 2000 Index or the S&P SmallCap 600 Index. Growth companies are companies the Adviser believes have above average growth potential. The Adviser considers a number of factors in determining a company's growth potential, such as whether the company is included in a third-party growth benchmark or classified as a growth company by a third-party vendor, if the company's projected earnings per share growth, sales growth per share or free cash flow growth or its trailing earnings per share growth is above the equity market median, if the company's research and…
From the fund's prospectus (filed Sep 24, 2026).
FCTGX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| FCTGX | +6.8% | +4.4% | +11.8% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Sep 30, 2026
What FCTGX costs
On a $10,000 investment, FCTGX's 1.4% expense ratio costs about $140 a year. The prospectus estimates $1,971 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
FCTGX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Fidelity Revere Street Trust | 4.31% |
| 2 | Fidelity Revere Street Trust | 1.70% |
| 3 | Brightspring Health Services Inc | 1.36% |
| 4 | Enova International Inc | 1.15% |
| 5 | Cogent Biosciences Inc | 1.11% |
| 6 | Interdigital Inc | 1.03% |
| 7 | Intapp Inc | 1.01% |
| 8 | Rush Street Interactive Inc | 0.87% |
| 9 | Spyre Therapeutics Inc | 0.87% |
| 10 | Xometry Inc | 0.84% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 14.2% of the fund. See all top 25 holdings and asset mix →
Alternatives to FCTGX
FCTGX FAQ
What is the expense ratio of FCTGX?
Is FCTGX a good investment?
What does FCTGX hold?
What is FCTGX's 5-year return?
Who manages FCTGX?
Other share classes of Fidelity Small Cap Growth Fund
- FCPGX · Fidelity Small Cap Growth Fund · 0.86%
- FCIGX · Fidelity Advisor Small Cap Growth Fund: Class I · 0.9%
- FCAGX · Fidelity Advisor Small Cap Growth Fund: Class A · 1.16%
- FIDGX · Fidelity Advisor Small Cap Growth Fund: Class Z · 0.79%
- FCCGX · Fidelity Advisor Small Cap Growth Fund: Class C · 1.9%